2019
DOI: 10.1038/s42256-019-0067-7
|View full text |Cite
|
Sign up to set email alerts
|

Automated de novo molecular design by hybrid machine intelligence and rule-driven chemical synthesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
52
0
3

Year Published

2019
2019
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 67 publications
(55 citation statements)
references
References 24 publications
0
52
0
3
Order By: Relevance
“…What we would really like to have is the ability to generate the molecules themselves 'de novo' (e.g. [59,64,65,84,[92][93][94][95][96][97][98][99][100][101][102][103][104][105][106][107]), by learning what amounts to a joint distribution over all the variables (both inputs and outputs). To this end, a generative model seeks to simulate or recreate how the data are generated 'in the real world'.…”
Section: Variational Autoencoders (Vaes) and Generative Methodsmentioning
confidence: 99%
“…What we would really like to have is the ability to generate the molecules themselves 'de novo' (e.g. [59,64,65,84,[92][93][94][95][96][97][98][99][100][101][102][103][104][105][106][107]), by learning what amounts to a joint distribution over all the variables (both inputs and outputs). To this end, a generative model seeks to simulate or recreate how the data are generated 'in the real world'.…”
Section: Variational Autoencoders (Vaes) and Generative Methodsmentioning
confidence: 99%
“…[4][5][6] In the context of in silico drug discovery, various techniques, such as virtual screening and de novo drug design, have been proposed to discover novel molecular structures in the vast chemical space. 7,8) Early works of de novo drug design used various algorithms, such as atom based elongation, fragment based combination, and reaction-driven design, to generate new molecular structures. [9][10][11][12][13] The structure-activity relationship (SAR) Matrix (SARM) method was designed to combine SAR visualization with new compound design.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, chemists enthusiastically applied advanced machine learning and artificial intelligence (AI) technologies toward the synthesis of drug molecules. For example, the AI-driven discovery of drug molecules [4][5][6], automated planning of synthetic routes [7][8][9], machine learning-driven optimization of reaction conditions [10][11][12] and autonomous assembly of synthetic processes [13][14][15].…”
Section: Introductionmentioning
confidence: 99%